Incorporating patient, nursing and environmental factors into antimicrobial stewardship: effects of simplifying treatment from cefuroxime to ceftriaxone
New Zealand Medical Journal · 2024
DOI: 10.26635/6965.6449 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Zealand Medical Journal, 2024. Verfasst von Michelle Balm und 7 weiteren Autor:innen. Beteiligte Einrichtung: Infectious diseases physician and clinical microbiologist, Infection Services, Te Whatu Ora Capital, Coast and Hutt Valley; Department of Microbiolog…. Hauptthemen laut MEDLINE: Cefuroxime, Anti-Bacterial Agents, Ceftriaxone, Antimicrobial Stewardship. Gefördert von: This work was supported by internal departmental funds..
Abstract (Originalsprache)
aim: Our antimicrobial guidelines (AGs) were changed in 2021 to recommend once-daily ceftriaxone in place of three-times-daily cefuroxime as preferred cephalosporin. This analysis sought to assess the effects of this on incidence of Clostridioides difficile infection (CDI), third-generation cephalosporin-resistant Enterobacterales (3GCR-E) and resource utilisation. method: Before and after analysis of 30-day CDI and 3GCR-E incidence following receipt of cefuroxime/ceftriaxone pre- and post-AG change. Total nursing time and waste production relating to cefuroxime/ceftriaxone delivery were calculated pre- and post-change. results: CDI incidence was 0.6% pre- and 1.0% post-change (adjusted odds ratio [aOR] 1.44, p=0.07) and 3GCR-E incidence 3.5% and 3.1% (aOR 0.90, p=0.33). Mean per-quarter estimated nursing administration time decreased from 2,065 to 1,163 hours (902 nursehour reduction) and antibiotic-related waste generation from 1,131kg to 748kg (383kg reduction). Overall days of therapy per-quarter of cefuroxime/ceftriaxone were unchanged between periods. conclusion: This simplification of our AG from a three-times-daily to a once-daily antibiotic resulted in considerable savings for our hospital (roughly 1.7 full-time equivalent nurses and over a tonne of waste yearly), with no significant increases in CDI or 3GCR-E. The impact of dosing schedules on non-antibiotic-spectrum factors, such as nursing time and resource usage, is worthy of consideration when designing AGs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infectious diseases physician and clinical microbiologist, Infection Services, Te Whatu Ora Capital, Coast and Hutt Valley; Department of Microbiology and Molecular Pathology, Awanui Laboratories Wellington.
- Infectious diseases physician, Infection Services, Te Whatu Ora Capital, Coast and Hutt Valley.
- Microbiology registrar, Department of Microbiology and Molecular Pathology, Awanui Laboratories Wellington.
- Antimicrobial pharmacist, Department of pharmacy, Te Whatu Ora Capital, Coast and Hutt Valley.
- Charge Nurse Manager Ward 7 North, Department of Surgical Services, Te Whatu Ora Capital, Coast and Hutt Valley.
Förderung
- This work was supported by internal departmental funds.
Zitieren
APA
Balm, M., Bupha-Intr, O., Sinha, T., Kelly, M., Stewart, L., Stephen, R., Blackmore, T., & Bloomfield, M. (2024). Incorporating patient, nursing and environmental factors into antimicrobial stewardship: effects of simplifying treatment from cefuroxime to ceftriaxone. New Zealand Medical Journal. https://doi.org/10.26635/6965.6449
Vancouver
Balm M, Bupha-Intr O, Sinha T, Kelly M, Stewart L, Stephen R, et al. Incorporating patient, nursing and environmental factors into antimicrobial stewardship: effects of simplifying treatment from cefuroxime to ceftriaxone. New Zealand Medical Journal. 2024. doi:10.26635/6965.6449
BibTeX
@article{Balm2024,
author = {Balm, Michelle and Bupha-Intr, Olivia and Sinha, Tanya and Kelly, Matthew and Stewart, Lucy and Stephen, Ruth and Blackmore, Tim and Bloomfield, Max},
title = {Incorporating patient, nursing and environmental factors into antimicrobial stewardship: effects of simplifying treatment from cefuroxime to ceftriaxone},
journal = {New Zealand Medical Journal},
year = {2024},
doi = {10.26635/6965.6449}
}
EUVIMED